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ABSTRACT: Murraya koenigii L. has been explored exhaustively and is known to possess more than 20 different carbazole-based alkaloids having multifarious 
therapeutic perception of this class of alkaloids, murrayanine is the highest explored alkaloid and is known to have (ethno)-pharmacological perspectives of 
purgative, astringent, febrifuge, anti-helminthic, anti-oxidant, anti-ulcerogenic, immunomodulation, etc. As murrayanine possess multiple sites for 
substituting wide-range of electron-donating / -withdrawing groups by semi-synthetic approach, in the present research, a chalcone; (E)-1-(1-methoxy-9H-
carbazol-3-yl)-3-(4-(methylsulfonyl)phenyl)prop-2-en-1-one was fabricated rationally by incorporating a natural portion (murrayanine) in the A-ring and a 
synthetic component (4-methylsulfonyl group) in the B-ring and screened against two bacterial species (Escherichia coli and Staphylococcus aureus) and two 
fungal species (Candida albicans and Aspergillus niger). The rationally designed chalcone demonstrated noteworthy anti-microbial activity. The fabricated 
chalcone was observed to be a better anti-bacterial agent as compared to its anti-fungal potentials. As compared to the standard drugs, the experimental 
molecule does hold well against pathogenic challenges. The present research therefore opened new avenues of judiciously developing a natural scaffold 
having an active methylsulfonyl group, which will inspire life science researchers across the globe in developing inhibitors with pronounced biological 
activity as compared with the parent compounds. 
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INTRODUCTION 
Murrayanine is a natural product obtained from Murraya koenigii L. (Rutaceae) (Mahapatra et al., 2018). It is a carbazole alkaloid known to have (ethno)-
pharmacological perspectives of purgative, astringent, febrifuge, anti-helminthic, anti-oxidant, anti-ulcerogenic, immunomodulation, etc (Mahapatra et al., 
2018a). Murraya koenigii L. has been explored exhaustively and is known to possess more than 20 different carbazole-based alkaloids having multifarious 
therapeutic perception (Shivhare et al., 2016) of this class of alkaloids, murrayanine is the highest explored and utilized component that finds its imperative 
role in the pharmacotherapeutics owing to diverse attributes like multiple sites for substituting wide-range of electron-donating / -withdrawing groups by 
semi-synthetic approaches, simple chemistry, and several other key factors (Mahapatra et al., 2018b).  Over the years, a number of heterocyclic hybrids have 
been reported by our research group. Murrayanine based therapeutically active heterocycles like oxazole, pyrimidine, thiazole, pyrazole, hydantoin, 
thiadiazole, phthalimide, isoxazole, benzodiazepine, benzoxazepine, and benzothiazepine have been fabricated which demonstrated tremendous potentials 
(Mahapatra et al., 2018c; Mahapatra et al., 2018d; Mahapatra et al., 2017; Mahapatra et al., 2017a; Mahapatra et al., 2017b; Mahapatra et al., 2017c). 
 
Similarly, an effort has been made in rational designing of a natural scaffold “chalcone” by unifying the natural product ‘murrayanine’ with a synthetic 
component ‘4-methylsulfonyl’. Thereby, combining a natural portion with a synthetic part to yield a component which itself is of a natural constitution 
(Figure 1). In the majority of the cases, it has been observed that substituting an active synthetic group often enhances the biological activity (Mahapatra et 
al., 2017d). In the upcoming research, several hybrids of natural products are evidenced which have demonstrated superior activity than the parent moieties 
from which they have derived (Mahapatra et al., 2017e). The methylsulfonyl group finds its significance in compounds exhibiting anti-inflammatory (Lim et al., 
2017), anti-allergic (Guda et al., 2013), anti-bacterial, anti-fungal, and anti-cancer activity (Lad et al., 2017). As a result of these, the methylsulfonyl group was 
included in our fabricated product with an expectation of pronounced biological activity. 
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Figure 1. The rationale for the development of (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl)phenyl)prop-2-en-1-one 
 
Chalcone or benzylideneacetophenone or 1,3-diphenyl-2E-propene-1-one is an open chain intermediate in the synthesis of aurones of the flavones 
pathway and subsist in numerous conjugated forms as the originator of many flavonoids and isoflavonoids compounds (Mahapatra & Bharti, 2016). They 
have been reported to exhibit anti-hypertensive, anti-arrhythmic, anti-obesity, anti-platelet, hypolipidemic (Mahapatra et al., 2016), anti-histaminic, anti-gout, 
anti-ulcer, anti-inflammatory (Mahapatra et al., 2017f), anti-filarial, anti-malarial, anti-tubercular, anti-fungal, anti-retroviral, anti-bacterial, anti-protozoal 
(Mahapatra et al., 2015), anti-neoplastic, anti-oxidant, anti-angiogenic (Mahapatra et al., 2015a), anti-diabetic (Mahapatra et al., 2015b), etc. The 
methylsulfonyl containing chalcone gained prime attention on account of anti-oxidant, anti-bacterial, anti-fungal (Kamble et al., 2011), anti-inflammatory, 
anti-nociceptive (Razmi et al., 2013), and anti-cancer activity (Ismail et al., 2013).  
In the present research, a chalcone was fabricated rationally by incorporating a natural portion (murrayanine) in the A-ring and a synthetic component 
(4-methylsulfonyl group) in the B-ring and screened against two bacterial and two fungal species. 
 
MATERIALS AND METHODS 
Chemicals and Instrumentation 
4′-(methylsulfonyl) acetophenone, the reactant, was purchased from Sigma Aldrich, Germany. The reagents and chemicals employed for the extraction of 
murrayanine and for experimental studies were of analytical grade and procured from HiMedia Ltd., India. The spectral data were obtained using the 
following: FT-IR study (KBr based Shimadzu® IRAffinity-1 instrument); 1H-NMR study (Bruker Avance-II instrument, calibrated using the internal standard 
tetramethylsilane); and mass study (MICROMASS Q-TOF instrument). The progress of the reaction was detected by pre-coated TLC plates of silica gel-G 
(Merck, India). CHN analysis was performed on PerkinElmer 2400 model Elemental Analyzer. 
 
Extraction of murrayanine 
The starting compound murrayanine (1) was isolated based on our previous reports (Mahapatra et al., 2017). The powdered M. koenigii stem bark was 
extracted with n-hexane employing silica gel-based column chromatography and the obtained hexane fractions (B21-B37) were inspected by thin layer 
chromatography. The product was further concentrated using the vacuum rotary evaporator. 
 
Synthesis of target compounds 
The semi-synthesis involved reaction of –CHO portion (aldehyde) of murrayanine (1) with the acetyl part (-COCH3) of the methylsulfonyl containing 
acetophenone (2) in the presence of the ethanolic NaOH solution to form a benzylideneacetophenone (chalcone) scaffold (3) comprising of a carbonyl 




Scheme 1. Semi-synthetic approach for the fabrication of chalcone based compound. 
 
Synthetic protocol for (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl) phenyl) prop-2-en-1-one (3) 
In the presence of an aqueous solution of sodium hydroxide (20 mL) containing 90% ethanol (25 mL), an equal concentration (0.01 M) of murrayanine (1) and 
4′-(methylsulfonyl) acetophenone (2) were reacted in reflux system for the period of 3 hr. For overnight, the reaction content was made to stand and the 
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mixture was added over the ice (containing a few drops of dilute HCl) with stirring to precipitate out the solid product. The obtained chalcone (3) was 
filtered, washed properly, and recrystallized suitably. 
 
61% yield; FTIR (KBr) υ (cm-1): 3199 (-NH, stretching), 3121 (C-H, aromatic), 1686 (C=O), 1619 (C=C, aromatic), 1573 (-NH, bending), 1304 (C-N), 1248 (C-O), 
1056 (S=O); 1H NMR (δ, ppm, CDCl3): 10.14 (9, 1H), 7.2-8.5 (Aromatic, 10H), 3.77 (1, 3H), 3.29 (17, 3H). MS: M+ 405. Anal. Calcd. for C23H19NO4S: C, 68.13; H, 4.72; 
N, 3.45. Found: C, 67.88; H, 4.29; N, 3.14. 
 
Anti-microbial screening 
The fabricated chalcone (3) was screened both for anti-bacterial studies against Escherichia coli (E. coli, MTCC 2961) and Staphylococcus aureus (S. aureus, 
MTCC 3160), and also for anti-fungal studies against Candida albicans (C. albicans, MTCC 227) and Aspergillus niger (A. niger, MTCC 277). The study was 
performed by disc diffusion method against these pathogens by employing Muller Hinton Agar medium (for anti-bacterial) / Potato dextrose agar medium 
(for anti-fungal). Initially, the species were cultured in the nutrient broth environment followed by incubation at 37°C for 24 hr. Subsequently, the cultured 
microbial cells were transferred onto the specific agar plates under a laminar flow cabinet. The experimental compound was dissolved in dimethylsulfoxide 
(DMSO), soaked over Whatman filter paper, kept over the bacterial plates, and incubated at 37ºC for 24 hrs (for anti-bacterial) / 28±2ºC for 72 hrs (for anti-
fungal). The anti-microbial potential was measured from the zone of inhibition diameter (in mm) using ciprofloxacin (for anti-bacterial) / fluconazole (for anti-
fungal) as the positive control and DMSO as the negative control (Telrandhe et al., 2017). The minimum inhibitory concentration (MIC) was determined by the 
agar streak dilution method which involved the preparation of microbial suspension containing 105 CFU/mL (approximately) and applied to the petridish 
with serial dilution in DMSO. The required quantity of the suspension containing the test sample was transferred at a temperature of40-50ºC into a petridish, 
up to 4-5 mm depth and permitted to set aside. The microbial content was incubated at 37±1ºC. The MIC values were measured in triplicate manner and their 
average was taken. Ciprofloxacin (for anti-bacterial) / fluconazole (for anti-fungal) was employed as the positive control and DMSO as the negative control 
(Kamble et al., 2017). 
 
RESULTS AND DISCUSSION 
Chemistry 
The FT-IR spectra revealed several crucial aspects which aided in the structure determination. The vanishing of respective aldehydes peak in the spectra of 
the starting material murrayanine (1) and evolution of a new peak of the C=O at 1686 cm-1 in IR-spectra supported the formation of chalcone (3). The 
determined ratios of carbon, hydrogen, and nitrogen by the elemental analysis further supported the fabrication of the new compound. The 1H-NMR spectra 
helped to obtain vital structural information. The observed range of 7.2-8.5 ppm presented the existence of 10 aromatic protons. The methyl protons of the 
methylsulfonyl group were chiefly noticed at 3.29 ppm, confirming the unification of the synthetic component at ring-B of the chalcone. Additionally, the 
protons of the methoxy group were chiefly located at 3.77 ppm. The –NH section of the murrayanine was principally seen at 10.14 ppm, thereby, further 
confirming the presence of natural portion in the ring-A of the chalcone. Besides the obtained data, the mass spectra finally confirmed the formation of the 
proposed compound due to the appearance of the base peak corresponding with the molecular weight of the chalcone (3). The fragment peaks (m/z 100-
175) represented the fragmentation of the molecule into respective aromatic fragments. 
 
Anti-microbial study 
The formed product (3) expressed noteworthy anti-microbial activity. The fabricated chalcone was observed to be a better anti-bacterial agent as compared 
to its anti-fungal potentials. The molecule exhibited the best growth inhibition of E. coli as compared to S. aureus. The anti-fungal activity of the compound 
was displayed best against A. niger than C. albicans (Table 1). However, a marked difference in the inter- and intra-variability was not observed. As compared 
to the standard drugs, the experimental molecule does hold well against pathogenic challenges. Therefore, from this study, an anti-infective perspective was 
found for the novel chalcone. 
 
CONCLUSION 
The rationally designed chalcone; (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl) phenyl) prop-2-en-1-one, comprising of both natural 
(murrayanine) and synthetic (4-methylsulfonyl) components demonstrated noteworthy anti-microbial activity. The fabricated chalcone was observed to be a 
better anti-bacterial agent as compared to its anti-fungal potentials. As compared to the standard drugs, the experimental molecule does hold well against 
pathogenic challenges. The present research, therefore, opened new avenues of judiciously developing a natural scaffold having an active methylsulfonyl 





Authors are highly thankful to Savitribai Phule Pune University, Pune, Maharashtra, India for providing research grants (Grant No. 13PHM000126). 
 
REFERENCES 
1. Guda DR, Park SJ, Lee MW, Kim TJ, Lee ME. Syntheses and anti-allergic activity of 2-((bis (trimethylsilyl) methylthio/methylsulfonyl) methyl)-5-
aryl-1, 3, 4-oxadiazoles. Eur J Med Chem 2013;62:84-8. 
2. Ismail B, Ghezali L, Gueye R, Limami Y, Pouget C, Leger DY, Martin F, Beneytout JL, Duroux JL, Diab-Assaf M, Fagnere C. Novel methylsulfonyl 
chalcones as potential antiproliferative drugs for human prostate cancer: Involvement of the intrinsic pathway of apoptosis. Int J Oncol 
2013;43(4):1160-8. 
International Journal of Agricultural and Life Sciences- IJALS (2018), Volume 4 (2) pp.236-240 
 http://dx.doi.org/10.22573/spg.ijals.018.s12200090 
 Available online at http://www.skyfox.co 
 
                                                                           ISSN: 2454-6127 
 
© 2018 The Author(s). Published by Skyfox Publishing Group.           
                239 
 
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited. 
3. Kamble MA, Mahapatra DK, Dhabarde DM, Ingole AR. Pharmacognostic and pharmacological studies of Bombax ceiba thorn extract. J Pharm 
Pharmacog Res 2017;5(1):40-54. 
4. Kamble VM, Hatnapure GD, Keche AP, Biradjar S, Patil SG, Tale RH, Rodge AH, Turkar SS, Gour K. Synthesis and Biological Evaluation of a Novel 
Series of Methoxylatedchalcone as Antioxidant and Anti-microbial Agents. J Chem Pharm Res 2011;3(6):639-48. 
5. Lad NP, Manohar Y, Mascarenhas M, Pandit YB, Kulkarni MR, Sharma R, Salkar K, Suthar A, Pandit SS. Methylsulfonyl benzothiazoles (MSBT) 
derivatives: Search for new potential antimicrobial and anticancer agents. Bioorg Med Chem Lett 2017;27(5):1319-24. 
6. Lim H, Kim HJ, Jeong H, Park HR. Anti-inflammatory effects of 1-isothiocyanato-7-(methylsulfonyl) heptane by suppressing the NFκ-B signaling 
pathway. Eur J Inflam 2017;15(2):57-65. 
7. Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: 
Synthesis, Characterization and Molecular Docking Studies. MOJ Bioorg Org Chem 2018;2(2):47-51. 
8. Mahapatra DK, Shivhare RS, Gupta SD. Anxiolytic activity of some 2,3-dihydrobenzo[b][1,4]oxazepine derivatives synthesized from Murrayanine-
Chalcone. Asian J Res Pharm Sci 2018a;8(1):25-29. 
9. Mahapatra DK, Shivhare RS, Asati V. Locomotor inhibitory activity of some Murrayanine-Chalcone based 2,3-dihydrobenzo[b][1,4]thiazepine 
derivatives: Exploring Anxiolytic potentials. Chronicle Pharm Sci 2018b;2(1):462-468. 
10. Mahapatra DK, Shivhare RS, Ugale VG. Anti-inflammatory potentials of some novel Murrayanine containing 1,3,4-Oxadiazole derivatives. Asian J 
Pharm Technol 2018c;8(1):47-51. 
11. Mahapatra DK, Shivhare RS, Kumar P. Murrayanine-chalcone transformed into novel pyrimidine compounds demonstrated promising anti-
inflammatory activity. Asian J Pharm Res 2018d;8(1):6-10. 
12. Mahapatra DK, Bharti SK, Eds. Handbook of Research on Medicinal Chemistry. New Jersey: Apple Academic Press, 2017. 
13. Mahapatra DK, Shivhare RS, Joseph TM. Design and characterization of Murrayanine linked Isoxazole derivatives: Novel class of bacteriocidal 
agents. Int J Res Drugs Pharm Sci 2017;1(1):11-15. 
14. Mahapatra DK, Shivhare RS, Bharti SK. Novel Murrayanine based Pyrazole analogs as emerging anti-fungal candidates: Design, synthesis, 
characterization, and in vitro evaluation. Res Pharm 2017a; 1(1): 1-5. 
15. Mahapatra DK, Shivhare RS. Synthesizing an anti-oxidant principle 2-(((1-methoxy-9H-carbazol-3-yl)methylene)amino)isoindoline-1,3-dione 
from N-aminophthalimide and murrayanine. Inventi Med Chem 2017b;2017(4):1-3. 
16. Mahapatra DK, Shivhare RS, Haldar AGM. Novel Schiff’s base containing Murrayanine–1,3,4-Thiadiazole Hybrids as potential anti-inflammatory 
agents. Asian J Chem Pharm Sci 2017c;2(2):10-15. 
17. Mahapatra DK, Das D, Shivhare RS. Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: 
Future EGFR Kinase inhibitors. In J Pharm Sci Drug Res 2017d;9(3):139-144. 
18. Mahapatra DK, Chhajed SS, Shivhare RS. Development of Murrayanine-Chalcone hybrids: An effort to combine two privilege scaffolds for 
enhancing hypoglycemic activity. Int J Pharm Chem Anal 2017e;4(2):30-34. 
19. Mahapatra DK, Bharti SK, Asati V. Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives. Curr Top Med Chem 
2017f;17(28):3146-69. 
20. Mahapatra DK, Bharti SK, Asati V. Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives. Eur J Med Chem 
2015;101:496-524. 
21. Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: Structural and molecular target perspectives. Eur J Med Chem 2015a;98:69-114. 
22. Mahapatra DK, Asati V, Bharti SK. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological 
perspectives. Eur J Med Chem 2015b;92:839-65. 
23. Shivhare RS, Mahapatra DK, Nair RR, Deshmukh SN. Schiff’s base derivatives of murrayanine demonstrated enhanced anti-oxidant activity than 
its parent moiety. Indian J Pharm Edu Res 2016;50(3):9-15. 
24. Telrandhe R, Mahapatra DK, Kamble MA. Bombax ceiba thorn extract mediated synthesis of silver nanoparticles: Evaluation of anti – 









Table 1. Anti-microbial activity of the synthesized chalcone. 
Compounds E. coli S. aureus C. albicans A. niger 
3 24.11±0.94 (25) 26.34±1.12 (25) 20.57±1.24 (25) 21.44±0.89 (25) 
Ciprofloxacin 33.73±1.76 (6.25) 31.28±1.69 (6.25) - - 
Fluconazole - - 31.83±1.81 (6.25) 32.54±1.37 (6.25) 
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